In vivo anticancer study of sodium 2‐[(4‐oxidobenzylidene)amino]‐6H‐1,3,4‐thiadiazine‐5‐olate against Ehrlich ascites carcinoma via targeting PI3K/mTOR pathway
Article in Chemical Biology & Drug Design (January 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Chemical Biology & Drug Design (January 2024)
Article in Results in Chemistry (January 2024)
Article in Current Chinese Science (January 2024)